Roth Capital Issues Negative Outlook for Vitalhub Earnings

Key Points

• Roth Capital has lowered its Q3 2025 earnings estimates for Vitalhub Corp. to $0.04 per share, down from a previous estimate of $0.05, alongside forecasts for future earnings also being adjusted downward.
• Several analysts have issued mixed reviews on Vitalhub, with TD Securities and National Bank Financial both upgrading their target prices and ratings to "buy" and "outperform," while Roth's revision represents a bearish outlook.
• Vitalhub's stock is currently trading at C$13.51, with a market cap of C$730.79 million, and has experienced a price range between a low of C$7.62 and a high of C$14.64 over the past year.

Vitalhub Corp. (TSE:VHI - Free Report) - Equities researchers at Roth Capital decreased their Q3 2025 earnings estimates for Vitalhub in a research report issued to clients and investors on Monday, August 11th. Roth Capital analyst R. Baldry now forecasts that the company will post earnings of $0.04 per share for the quarter, down from their prior forecast of $0.05. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. Roth Capital also issued estimates for Vitalhub's FY2025 earnings at $0.14 EPS, Q2 2026 earnings at $0.07 EPS and Q4 2026 earnings at $0.08 EPS.

VHI has been the topic of a number of other research reports. National Bankshares set a C$14.00 price objective on shares of Vitalhub and gave the stock an "outperform" rating in a report on Tuesday, June 10th. Scotiabank boosted their target price on shares of Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a report on Friday, June 20th. Raymond James Financial boosted their target price on shares of Vitalhub from C$14.50 to C$15.00 and gave the stock an "outperform" rating in a report on Tuesday, August 12th. National Bank Financial raised shares of Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. Finally, TD Securities boosted their target price on shares of Vitalhub from C$15.00 to C$16.00 and gave the stock a "buy" rating in a report on Monday, August 11th. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Vitalhub presently has an average rating of "Buy" and a consensus target price of C$13.75.

Vitalhub Price Performance

Shares of VHI traded up C$0.02 on Wednesday, reaching C$12.75. The company's stock had a trading volume of 291,394 shares, compared to its average volume of 149,335. The stock has a market capitalization of C$689.68 million, a P/E ratio of 207.37, a PEG ratio of 1.18 and a beta of 1.26. The stock's 50 day simple moving average is C$12.13 and its two-hundred day simple moving average is C$10.93. Vitalhub has a 12-month low of C$7.62 and a 12-month high of C$14.64.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.